Link Search Menu Expand Document


The CyLinter project is supported by:

  • NCI grants U54-CA22508U2C-CA233262 and U2C-CA233280 as part of the Human Tumor Atlas Network.
  • NIH grant 1U54CA225088: Systems Pharmacology of Therapeutic and Adverse Responses to Immune Checkpoint and Small Molecule Drugs as part of the Center For Cancer Systems Biology Consortium.
  • Ludwig Center at Harvard Medical School and the Ludwig Cancer Research Foundation